Meeting
2018 Genitourinary Cancers Symposium
Impact of genomic risk scores on treatment decisions following radical prostatectomy in a prospective Medicare registry.
Authors
John L. Gore
University of Washington School of Medicine, Seattle, WA
John L. Gore , Darlene Dai , Robert Benjamin Den , Kasra Yousefi , Tiffany Le , Marguerite Du Plessis , Roanna Padre , Worlanyo Sosu-Sedzorme , Elai Davicioni , Paul L. Nguyen , Ashley Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 72)
DOI
10.1200/JCO.2018.36.6_suppl.72
Abstract #
72
Poster Bd #
D14
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Validation of the decipher genomic classifier (GC) in SAKK 09/10: A phase III randomized trial of dose-escalated salvage radiotherapy (SRT) after radical prostatectomy (RP).
First Author: Alan Dal Pra
Poster
2018 Genitourinary Cancers Symposium
Impact of decipher test on adjuvant and salvage treatments received following radical prostatectomy.
First Author: John L. Gore
Poster
2016 ASCO Annual Meeting
Validation of a genomic risk classifier to predict prostate cancer-specific mortality (PCSM) in high-risk patients.
First Author: Jeffrey Karnes
Poster
2016 Genitourinary Cancers Symposium
Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk.
First Author: Robert Den